Autogenomics
1 known investors
AutoGenomics develops the INFINITI system and proprietary BioFilmChip microarrays that automate multiplexed genetic analysis, letting clinical laboratories run large menus of tests from a single sample. Its products span pharmacogenomics, toxicology, chemistry, and pathology to give physicians results that inform treatment and therapy choices.
Investors · 1
Frequently asked questions
- What does Autogenomics do?
- AutoGenomics develops the INFINITI system and proprietary BioFilmChip microarrays that automate multiplexed genetic analysis, letting clinical laboratories run large menus of tests from a single sample. Its products span pharmacogenomics, toxicology, chemistry, and pathology to give physicians results that inform treatment and therapy choices.
- Who are Autogenomics's investors?
- Autogenomics's investors include Bantam Group.